Regeneron, Sanofi expand antibody deal for $1B upfront

- Regeneron and Sanofi expanded their antibody partnership to develop new treatments, with Sanofi paying $1 billion upfront.
- The companies plan to move three specific antibodies into clinical studies by 2027, with future profits split 50:50.
- Regeneron will manage the research while Sanofi handles sales, meaning the commercial success of these drugs depends on regulatory approval from agencies like the FDA.
Sources & Citations
1 sourceMore Stories
Fractured ecosystems, climate change raise risk of zoonotic, vector-borne disease outbreaks, study finds
• An international research group published a study in Nature yesterday finding that ecosystem fragmentation and climate-driven rainfall declines increase the risk of disease outbreaks. • The researchers analyzed more than 58,000 outbreaks of 32 different diseases across 169 countries.
Read original · cidrap.umn.eduFive countries and territories recognized for disease elimination achievements in the Americas - PAHO/WHO
• The Pan American Health Organization recognized five countries and territories in the Americas on September 29, 2026, for successfully eliminating specific diseases over the past year. • These achievements contribute to a broader regional target to eliminate more than 30 communicable diseases, which are illnesses that spread from one person to another, by 2030.
Read original · paho.orgNew food safety strategy aims to reduce the burden of foodborne diseases affecting 43 million people in the Americas - PAHO/WHO
• Health authorities from the Americas approved a new regional strategy on September 30, 2026, to strengthen food safety systems and reduce foodborne diseases. • The strategy targets a crisis that affects an estimated 43.7 million people and causes approximately 78,000 deaths in the region every year.
Read original · paho.orgHealthy Americas Foundation Report Too Many Drugs Tested on Patients Who Are Not the Ones Who Will Take Them
• The Healthy Americas Foundation released a report reviewing every novel drug approved by the FDA in 2025 and their pivotal trials. • Data from FDA Drug Trials Snapshots shows that only about 1 in 5 participants in cancer, heart, blood, kidney, and endocrine trials were enrolled in the United States.
Read original · prnewswire.comNanoViricides, Inc. (NASDAQ:NNVC) |
• NanoViricides, Inc. filed its Annual Report on Form 10-K with the SEC, detailing the progress of its antiviral drug NV-387. • The company is conducting Phase II trials for NV-387 to treat Ebola and Mpox, noting that there is currently no approved drug for Mpox Clade I or Clade II.
Read original · webdisclosure.comMAHA summit highlights innovations reshaping American healthcare | News
• Dozens of healthcare innovation leaders gathered for the second Make America Healthy Again Summit to address national health priorities. • The summit focused on reversing the chronic disease epidemic and increasing the amount of control Americans have over their own health.
Read original · sanfordherald.comWhy Observational Studies Lie to You
• The author warns readers that observational studies often produce misleading results regarding the effectiveness of long-term drug therapies. • These studies frequently suffer from healthy user bias, where the people taking the drug are already healthier than those who are not.
Read original · brownstone.org
Brownstone InstituteCountries of the Americas adopt new strategy to strengthen health security - PAHO/WHO
• Health authorities from the Americas approved a new regional strategy on health security on September 30, 2026. • The Pan American Health Organization (PAHO) designed the plan to improve how countries prevent, prepare for, and respond to health emergencies.
Read original · paho.orgHealth Matters newsletter: The question of access to healthcare - The Hindu
• Scientists at the Institute of Animal Virology (IAV) in Kerala are developing an early-warning system to forecast dengue trends and anticipate outbreaks. • The project utilizes artificial intelligence to improve medical imaging, clinical decision-making, and the development of drugs and vaccines.
Read original · thehindu.comMedical Bulletin 30/September/2026
• A study found that nearly 95% of viral TikTok videos promoting Korean skincare and "glass skin" make misleading claims. • Researchers analyzed viral content to determine how often skincare benefits were exaggerated or unsupported.
Read original · medicaldialogues.inMAHA summit highlights innovations reshaping American healthcare
• The second Make America Healthy Again Summit recently gathered healthcare innovators to discuss reversing the chronic disease epidemic and increasing patient autonomy. • Featured technologies included a GRAIL blood test capable of detecting over 50 types of cancer before symptoms appear and psychedelic medicines for mental health from Compass Pathways and Definium Therapeutics.
Read original · yahoo.com